Search results for: 'part cold consumer behavior saudi'
- Related search terms
- part 01 00 00 00
- parts 01 00 00 00
- parts solutions in the global hydrogen production market
- part make industry market
- part more industry market
-
30 Dec 2022  |  Global  |  Market Research
Growth Opportunities in Global Pharmaceutical Logistics
Cold chain Investments and Hybrid Clinical Trials to Ensure Transformational Growth of Pharmaceutical Logistics
Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure ...
$2,450.00
Special Price $1,837.50 save 25 %
-
17 Nov 2021  |  Global  |  Market Research
Global Pharmaceutical Packaging Growth Opportunities
The Growing Pipeline of Temperature-sensitive Biologics Products and Healthcare Stakeholders’ Higher Stake in Patient Health Outcomes will Drive Investments
The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...
$2,450.00
Special Price $1,837.50 save 25 %
-
06 Jun 2018  |  Global  |  Market Research
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of t...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028
GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Nov 2023  |  Global  |  Technology Research
Growth Opportunities in Obesity Drugs and Delivery Platforms
GLP-1-based Drugs, Along With Injector and Nanomaterial Delivery Platforms, Drive Transformational Industry Growth
The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Dec 2019  |  Global  |  Technology Research
Emerging Microbiome Technologies for Applications in Skin Care
Microbiome-based Innovations Transforming the Personal Care Landscape
Skin microbiome industry has been rapidly evolving since the past few years and is likely to witness new innovations in the near future. Apart from emerging new start-ups in this area, several leading cosmetic and industry participants are likely to shift focus towards emerging microbiome-based beauty platforms.As the consumer focuses towards the...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jul 2024  |  Global  |  Technology Research
Menopause Care Management Technology Growth Opportunities, 2024 2029
Growing competitive intensity fuels future growth potential in menopause care management
As the global population ages, more attention should be paid to the needs of individuals aged 45 to 55, particularly women in the perimenopausal and menopausal stages. Women aged 45 and above are at a crucial stage in terms of professional and personal responsibilities; however, they are challenged by menopausal symptoms, such as hot flashes, sleep...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Oct 2020  |  Global  |  Market Research
Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026
Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities
The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 May 2023  |  Global  |  Market Research
Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector
Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential
This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...
$4,950.00
Special Price $3,712.50 save 25 %